(Q41721827)

8 October 2017

title

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis (English)

1 reference

8 October 2017

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Helmut Butzkueven

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Tomáš Kalinčík

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mark Slee

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Maria Trojano

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Alessandra Lugaresi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Vilija Jokubaitis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Eugenio Pucci

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Vincent van Pesch

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Maria Pia Amato

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

Guillermo Izquierdo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

4

Pierre Duquette

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

30

Eva Havrdova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

Jose Antonio Cabrera-Gomez

10 June 2020

23

Jose Antonio Cabrera-Gomez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

14

Cavit Boz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

15

Gerardo Iuliano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

10

Raymond Hupperts

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jeannette Lechner-Scott

21

Jeannette Lechner-Scott

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

8

Celia Oreja-Guevara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

24

Maria Laura Saladino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

20

Freek Verheul

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

19

Edgardo Cristiano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Daniele L A Spitaleri

18

Daniele Spitaleri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

Ricardo Fernandez-Bolanos

10 June 2020

16

Ricardo Fernandez-Bolanos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

27

Orla Gray

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

26

Fraser Moore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Mark John Ingraham Paine

28

Mark Paine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

35

MSBase Study Group

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

5

Marc Girard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Francois Grand-Maison

11

Francois Grand'Maison

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

17

Shlomo Flechter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

6

Pierre Grammond

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

29

Michael Barnett

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Timothy Spelman

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Roberto Bergamaschi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

5 December 2014

1 reference

Multiple Sclerosis Journal

8 October 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1159-1171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Substantial gains in bias reduction from matching with a variable number of controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514559865

21 January 2018

Identifiers

DOI

10.1177/1352458514559865

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480857%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference